A B S T R A C T Human cardiac ventricular myosins were prepared from autopsy samples from nine adults, seven infants, and from surgical specimens from seven patients undergoing left ventricular septal myectomy for obstructive hypertrophic cardiomyopathy. Infant myosin differed from adult myosin in two important characteristics: (a) t-30% of the 27,000-dalton myosin light chain is replaced by a 28,000-dalton light chain, and (b) the actin-activated myosin MgATPase activity of infant myosin is significantly lower than that of adult myosin (64 nmol phosphate released/mg myosin per min vs. 124 nmol/mg per min at 37°C). The K+-EDTA ATPase activity of the myosin measured in 0.5M KC1 is also lower in infants (1,210 nmol/mg per min vs. 620 nmol/mg per min at 37°C), but the Ca++-activated ATPase is not significantly different. There were no differences in enzymatic activity between the normal adult and cardiomyopathic myosins.
INTRODUCTION
The existence of isoenzymes of cardiac myosin has been postulated to explain the correlation between in vitro myosin ATPase activity and altered myocardial contractile properties of disease states (1) (2) (3) . Recently, new myosins have been demonstrated in animal models of cardiac hypertrophy that differ from controls in primary structure. The myosin molecule is dimeric, being composed of two 200,000-dalton heavy chains and two pairs of light chains, which in ventricular myocardium are -20,000 and 27,000 daltons. Isoenzyme variants, differing in either the heavy or light chains (or both), may account for the altered enzymatic activities seen in the myosins from hypertrophied myocardium (3) in man.
Flink and Morkin (4), using cyanogen bromide to cleave the polypeptide chains at methionine residues, showed the presence of a new myosin heavy chain isoenzyme in thyrotoxic rabbit hearts, which correlated with an increased actin-activated myosin MgATPase activity (5) (6) (7) (8) . Hoh (9) , using a technique for polyacrylamide gel electrophoresis (PAGE)' of intact native myosin in a glycerol-pyrophosphate buffer system, was able to separate three different ventricular myosin heavy chain isoenzymes (VI, V2, and V3, in order of decreasing velocity of migration) in rat heart (10) . These isoenzymes differ in Ca++-activated ATPase activity with Vl showing the highest, and V3 the low- ' Abbreviations used in this paper: DTT, dithiothreitol; MOPS, 4-morpholino-propane sulfonic acid; PAGE, polyacrylamide gel electrophoresis. est activity. Manipulations of the thyroid status (hypophysectomy and thyroxine replacement) were accompanied by appropriate shifts in isoenzyme distribution: the hypothyroid rats showed mostly V3, and thyroxine-replaced rats showed mostly Vl myosin. The isoenzyme patterns also varied with age, being completely Vl at 3 wk of age and showing increasing amounts of the V3 isoenzyme up through 12 wk of age. Conditions were thus available in which only one of the three isoenzymes would be present in the myocardium in a given animal: the hypothyroid rat shows only V3, and the weanling rat (3 wk of age) shows only VI myosin. That these electrophoretically different myosins are heavy chain isoenzyme variants is substantiated by differences in two-dimensional peptide maps performed following cleavage with cyanogen bromide. Differences in the methionine and arginine content, and in Ca++-activated ATPases (11, 12) are also reported for these two isoenzymes. There were no differences seen in myosin light chains in VI and V3 cardiac myosins by sodium dodecyl sulfate (SDS) PAGE.
Microcomplement fixation and pyrophosphate PAGE (13) (14) (15) (16) have also been used to demonstrate a change in distribution of the myosin heavy chain isoenzymes in rat hearts undergoing hypertrophy due to mechanical overload caused by aortic stenosis and regurgitation. With increasing hypertrophy there was a decrease in the proportion of VI myosin and an increase in that of V3 myosin along with an accompanying decrease in myosin Ca++-activated ATPase activity.
Marked changes in the distribution of these cardiac myosin heavy chain isoenzymes have also been seen in fetal and early postnatal development in the rat, rabbit, mouse, guinea pig, dog, pig, and beef hearts (17) . In each species, the slow migrating isoenzyme, V3, is the predominant form during fetal development. The VI isoenzyme appears during the perinatal period. In the rat and mouse VI becomes predominant and remains so throughout adult life. In the rabbit and pig, on the other hand, VI myosin appears only transiently, V3 myosin being the dominant isoenzyme in adulthood.
In addition to isoenzymes of the myosin heavy chain, the existence of a unique human fetal cardiac muscle myosin light chain isoenzyme has recently been demonstrated by Cummins (18) . This light chain of myosin (Mr, 28,000) is detectable in decreasing amounts from birth to 8 mo of age. It appears to migrate electrophoretically with an Rf identical to adult atrial myosin light chain and a development shift from atrial to ventricular myosin gene expression in the newborn period has been suggested.
In view of these recent advances in the study of cardiac myosin isoenzymes in animal models, the role of cardiac myosin isoenzyme variation in man was considered. An earlier paper from this laboratory (19) reported on purified myosin isolated from the ventricles of subjects with hypertrophic obstructive cardiomyopathy. These studies showed no differences between the myosins from patients with hypertrophic cardiomyopathy and normal hearts with respect to K+-EDTA or Ca++-activated ATPase The adult cardiac myosins were prepared from the left ventricular myocardium of eight adults and one juvenile (12 yr). The adult heart weights, recorded from the autopsy report, varied from 360 to 600 g. The ages ranged from 12 to 80 yr. Only three patients (patients 2, 6, and 9) had medical histories of hypertension and only one of these (patient 2) had clinical congestive heart failure. The remaining patients had no evidence of heart disease at autopsy.
There were specimens from five newborn premature infants expiring of pulmonary complications in the 1st wk of life, one from a full-term infant with lethal noncardiac congenital anomalies, and one from a 4 mo old with cerebral palsy. None had evident cardiac pathology. In each instance all atrial tissue was removed and the myocardium from both ventricles was pooled for myosin extraction. All autopsy specimens were frozen at the time of necropsy (<24 h post mortem) and stored at -30°C for a period of <3 mo before extraction.
Surgical specimens were obtained from seven patients with hypertrophic obstructive cardiomyopathy who underwent left ventricular septal myotomy and myectomy by Dr. A. G. Morrow (National Institutes of Health, Bethesda, MD) during this study (20) . All but one of these patients had resting left ventricular outflow tract obstruction (mean gradient 100 mm Hg, range 75-120 mm Hg); two had significant left ventricular free-wall thickening by echocardiogram. Operative samples were frozen and stored in a similar fashion and kept for an interval of <18 mo before extraction.
For technical controls for peptide maps and pyrophosphate polyacrylamide gel electrophoresis, myosin was also prepared from rat hearts at different development stages. These hearts are known to contain different mixtures of heavy chain isoenzymes (see above). Cardiac ventricular samples were obtained from Sprague-Dawley rats at 18-d (24) except that 32P radioactivity in the organic phase phosphomolybdate extract was measured rather than using the colorimetric procedure. The time-course of each assay, performed in triplicate, was linear.
Actin-activated myosin MgATPase activity was determined by a modification of the method previously described (25) . Human or rat cardiac myosin and rabbit skeletal muscle F-actin were mixed with 2 M KCI added to a final concentration of 0.5 M at 4°C. With gentle vortexing the mixture was diluted with cold water and a buffer of 12.5 mM MOPS, 2.5 mM MgCl2, 0.25 mM CaC12 to the final reaction conditions of 30 mM KCI, 10 mM MOPS (pH 7.0, 37°C), 2 mM MgCl2,0.2 mM CaC12, 0.1 mg/ml myosin, 0.5 mg/ml rabbit skeletal muscle actin, and 1 mM ATP. The reaction was started by the addition of ATP, and the time-course of 32p liberation was measured as above. The time-course of the reaction was generally nonlinear over 5 min, but using 30-s assay intervals over 2.5 min, linear reaction rates could be measured (Fig. 1) (9) . Gels were 5 X 110 mm, 3.88% acrylamide, 0.12% bis-acrylamide, 10% glycerol, 40 mM Na4P207, pH 8.5, run at 50 V for 24-36 h at 2-50C. The upper and lower buffer solutions were 40 mM Na4P207 (pH 8.5), 8.5% glycerol, and were recirculated to maintain equal pH and temperature. Two-dimensional PAGE was performed by the method of O'Farrell (29); the first dimension was isoelectric focusing (pH 3.5-10), the second dimension SDS-PAGE in a 20% acrylamide slab gel. Gels were stained with Coomassie Brilliant Blue and when appropriate were scanned using a Quick Scan (Helena Laboratories, Beaumont, TX). (Fig.  4) . To visualize a variety of peptides, time-courses for each digestion were run rather than comparing limit digests. Fig. 2 FIGURE 4 SDS-PAGE of chymotryptic digests of rat ventricular cardiac myosins. Samples run are: F, fetal rat; W, weanling rat; A, adult rat. Digest sampled at 0, 2, 4, 6, and 8 min. SDS-PAGE molecular weight standards (S), are run in the well on the extreme right. no evident differences. These results suggest that there is only a difference in light chains between infant and adult myosins, with no evident heavy chain difference.
RESULTS

Myosin
Pyrophosphate-PAGE. None of the human cardiac myosins studied demonstrated multiple isoenzyme bands on pyrophosphate gel electrophoresis. Furthermore, coelectrophoresis demonstrated no differences between normal and cardiomyopathic myosins, or between adult and infant myosins. As controls, samples of rat ventricular myosin, known to show a mixture of heavy chain isoenzymes, were run along with the human samples. Adult rat cardiac myosin separated into three distinct bands. Representative pyrophosphate polyacrylamide gels are shown in Fig. 5 .
Two-dimensional PAGE. To further analyze for possible heavy chain differences, cyanogen bromide cleavage maps of myosins from two normal adults, two patients with hypertrophic cardiomyopathy, and two infants were prepared. O'Farrell two-dimensional PAGE of these cyanogen bromide peptides (Fig. 6) showed no apparent qualitative differences. The benefit of the two-dimensional peptide mapping in the study of rat and rabbit cardiac myosin isoenzymes came from the discovery of conditions in which there was only a single isoenzyme expressed, such as hypothyroid rat for Vl (4) and Hoh (11) had docum-ented significant primary structure differences using only one-dimensional peptide maps, which lend themselves to quantitative scanning. One-dimensional cyanogen bromide peptide maps of cardiac muscle myosin from these patients also showed no differences (Fig. 7) .
DISCUSSION
The perinatal period in rat, rabbit, and other species is one of very rapid alterations in cardiac myosin heavy chain isoenzyme composition (17) (18, 30) , that the fetal light chain is not a proteolytic product of the myosin heavy chain. Our study shows that the fetal light chain appears to be relatively resistant to proteolysis, since it appears to persist following 10 min of digestion with chymotrypsin ( Fig. 2) and at least 2 mmI of digestion with papain (Fig. 3) .
That (17) .
If our deduction is correct and there is no difference in the heavy chain of myosin in human adults and infants, how then could the replacement of only 30% of the adult light chain by a fetal light chain result in a 50% decrease in actin-activated MgATPase activity? This is possible because myosin is a dimer containing two 27,000-dalton light chains. If the fetal myosin isoenzyme were a heterodimer, containing one 27,000-dalton adult light chain and one 28,000-dalton fetal light chain, then replacement of 30% of the 27,000-dalton light chains with the 28,000-dalton fetal light chain would amount to replacing 60% of the adult myosin isoenzyme molecules with fetal isoenzyme molecules (heterodimers). The finding of a 50% decrease in enzymatic activity would furthermore imply that there is an interaction between the two heads of infant myosin, at least with respect to the actin-activated MgATPase activity, similar to the recent findings with scallop myosin (34) .
It is of note that the myosin ATPase activities, peptide maps, and pyrophosphate gel electrophoreses were not different comparing normal human cardiac myosins to those myosins isolated from patients with hypertrophic cardiomyopathy. Maron et al. (19) reported no differences comparing these two groups with regard to K+-EDTA and Ca++-activated ATPase activities (in 0.5 M KCI) and SDS-PAGE. The present study, though confirming our earlier negative results, reports a comparison of hypertrophic cardiomyopathy with normal myosin incorporating techniques that have been useful in detecting myosin heavy chain structural differences in animal models of cardiac hypertrophy. The fact that all but one of the patients with hypertrophic cardiomyopathy had resting left ventricular outflow tract obstruction and pressure overload might have suggested that a different myosin species would be present in these hearts, as an adaptive mechanism similar to the rat pressure overload model (16) . It may be equally significant that there were no differences in actin-activated MgATPase activity or peptide maps within the adult group of myosins despite such a wide range in heart weights and ages. One patient in fact had congestive heart failure and cardiomegaly (heart weight 600 g) and yet was not distinguishable from the remaining adults by these tests. Swynghedauw et al. (35) and Leclerq et al. (36) , on the other hand, have observed a negative correlation between myofibrillar ATPase activity and heart weight in a series of 70 human autopsy hearts. The ATPase activity decreased markedly with heart weights >500 g.
There is not yet a biochemical explanation for the decreased myosin ATPase activity observed in human cardiac hypertrophy and failure. From the observation of Lompre et al. (17) that the adult man has predominantly a V3 myosin (i.e., one which is electrophoretically similar to the V3 myosin isoenzyme of rat and rabbit) it is unlikely that the same form of isoenzyme shift seen in rat with chronic cardiac overload would appear in man, because adult human myosin, differing from the rat, is already in the V3 form. For this reason cardiac hypertrophy in the rat may not be a suitable model for the study of myocardial hypertrophy in man. These interspecies variations underscore the difficulties in extrapolating from animal investigations of cardiac structure and function to the clinical setting.
In summary, human infant cardiac myosin contains a mixture of adult and fetal myosin light chain isoenzymes, has significantly lower actin-activated MgATPase and K+-EDTA ATPase activities than the adult, and has no evident differences in myosin heavy chain primary structure identifiable by peptide digest maps or pyrophosphate-PAGE. These findings suggest that the fetal 28,000-dalton light chain per se is responsible for the difference in enzymatic activities, and further that this peptide may be a useful probe in studies to further elucidate the role of the 27,000-dalton light chain in cardiac myosin function.
